NASDAQ: MIRM - Mirum Pharmaceuticals, Inc.

Yield per half year: +19.12%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Mirum Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., биофармацевтическая компания, занимается разработкой и коммерциализацией новых методов лечения изнурительных редких и орфанных заболеваний. Ведущим продуктом компании является ЛИВМАРЛИ, исследуемый пероральный препарат для лечения прогрессирующего семейного внутрипеченочного холестаза, а также для лечения синдрома Алажиля и атрезии желчевыводящих путей. Также разрабатывается препарат Воликсибат для лечения первичного склерозирующего холангита и первичного билиарного холангита у взрослых. Компания Mirum Pharmaceuticals, Inc.

more details
была зарегистрирована в 2018 году и имеет штаб-квартиру в Фостер-Сити, штат Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2019-07-18
ISIN US6047491013
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.mirumpharma.com
Цена ао 46.28
Change price per day: 0% (46.28)
Change price per week: -3.32% (47.87)
Change price per month: -7.31% (49.93)
Change price per 3 month: +10.11% (42.03)
Change price per half year: +19.12% (38.85)
Change price per year: +84.24% (25.12)
Change price per 3 year: +101.04% (23.02)
Change price per 5 year: +182.02% (16.41)
Change price per year to date: +13.99% (40.6)
All parameters

Underestimation

Title Value Grade
P/S 6.64 1
P/BV 4.97 3
P/E 0 0
EV/EBITDA -12.8 0
Total: 3.75

Efficiency

Title Value Grade
ROA, % -25.27 0
ROE, % -65.72 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -3.13 10
Total: 9.4

Growth impulse

Title Value Grade
Yield Revenue, % 1594.31 10
Yield Ebitda, % 149.33 10
Yield EPS, % -12.64 0
Total: 8
More

ETFShare, %Profitability for 1 year, %Dividends, %
Innovator IBD 50 ETF 3.02537 31.06 0.08939
Virtus LifeSci Biotech Products ETF 2.13686 36.79 0.13953
First Trust Small Cap Growth AlphaDEX Fund 0.64532 42.5 1.22182
First Trust Innovation Leaders ETF 0.62442 45.14 0.51521
iShares Micro-Cap ETF 0.3876 -13.97 1.54048
First Trust Small Cap Core AlphaDEX Fund 0.32871 -10.11 1.87983
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.25378 6.44 1.66828
Direxion Daily S&P Biotech Bull 3x Shares 0.21991 4067.92 0.25924
Future Tech ETF 0.1795 426.34 0.8416
Principal Healthcare Innovators ETF 0.1795 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.17848 28.58 0.8565
First Trust Multi Cap Growth AlphaDEX Fund 0.13656 41.56 1.02425
Vanguard Russell 2000 Growth ETF 0.13 -10.8 0.60264
ProShares Ultra Nasdaq Biotechnology 0.11877 51.7 0.85651
iShares Russell 2000 Growth ETF 0.11267 38.04 0.6026
Vanguard Russell 2000 ETF 0.06 -10.48 1.48801
iShares Morningstar Small-Cap Growth ETF 0.05575 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.05575 572.1 0.72598
Schwab U.S. Small-Cap ETF 0.04093 -10.22 1.51433
ProShares UltraPro Russell2000 0.033 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.02842 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.02842 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.02157 -4.29 1.46057
ProShares Hedge Replication ETF 0.00911 5.92 1.47892
Humankind US Stock ETF 0.00517 18.81 1.99919
Schwab U.S. Broad Market ETF 0.00302 -0.4495 1.43354
iShares Russell 3000 ETF 0.00274 0.0303 1.43482
Dimensional US Core Equity Market ETF 0.00031 30.98 1.40618
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.31226.851.13



Head Job title Payment Year of birth
Mr. Christopher Peetz CEO & Director 1.09M 1979 (46 years)
Mr. Peter Radovich M.B.A., Ph.D. COO & President 732.15k 1978 (47 years)
Dr. Pamela Vig Ph.D. Chief Scientific Officer 678.2k 1971 (54 years)
Ms. Lara Longpre MBA, MSC Chief Development Officer 678.2k 1970 (55 years)
Andrew McKibben Vice President of Investor Relations and Finance N/A
Mr. Paul K. Ross Chief Compliance Officer N/A
Ms. Erin Campany Senior Vice President of Human Resources N/A 1968 (57 years)
Ms. Vinita P. Kumar Senior vice President of Quality N/A
Mr. Eric H. Bjerkholt M.B.A. Chief Financial Officer N/A 1960 (65 years)
Dr. Jean-Luc Girardet Ph.D. Senior Vice President of Technical Operations

Address: United States, Foster City. CA, 950 Tower Lane - open in Google maps, open in Yandex maps
Website: https://www.mirumpharma.com